By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Vanda Pharmaceuticals, Inc. 

9620 Medical Center Drive
Suite 201
Rockville  Maryland  20850  U.S.A.
Phone: 301-294-9300 Fax: 301-294-1900


SEARCH JOBS


Industry
Pharmaceutical






Company News
Vanda Pharmaceuticals, Inc. (VNDA) To Announce Third Quarter 2014 Financial Results On October 27, 2014 10/14/2014 12:23:31 PM
Vanda Pharmaceuticals, Inc. (VNDA) Reports Second Quarter 2014 Results 8/7/2014 9:34:19 AM
Vanda Pharmaceuticals, Inc. (VNDA) To Announce Second Quarter 2014 Financial Results On August 7, 2014 7/18/2014 10:03:14 AM
Vanda Pharmaceuticals, Inc. (VNDA) Release: European Medicines Agency Accepts HETLIOZ™ (Tasimelteon) Marketing Authorization Application For Non-24-Hour Sleep-Wake Disorder In The Totally Blind 6/3/2014 9:26:31 AM
Vanda Pharmaceuticals, Inc. (VNDA) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/30/2014 6:53:36 AM
Vanda Pharmaceuticals, Inc. (VNDA) Reports First Quarter 2014 Results 5/8/2014 7:12:07 AM
Vanda Pharmaceuticals, Inc. (VNDA) To Announce First Quarter 2014 Financial Results On May 8, 2014 4/25/2014 6:39:08 AM
Vanda Pharmaceuticals, Inc. (VNDA) Announces Availability of HETLIOZ™ (tasimelteon) For Non-24-Hour Sleep-Wake Disorder (Non-24) 4/10/2014 9:44:15 AM
Vanda Pharmaceuticals, Inc. (VNDA) Reports Fourth Quarter 2013 And Full Year 2013 Results 2/13/2014 11:14:10 AM
FDA Approves Vanda Pharmaceuticals, Inc. (VNDA)'s Sleep Disorder Drug HETLIOZ™ 2/3/2014 6:44:54 AM
12345678910...
//-->